Jocelyn Moyes to Influenza Vaccines
This is a "connection" page, showing publications Jocelyn Moyes has written about Influenza Vaccines.
Connection Strength
1,564
-
Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
Score: 0,821
-
A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa. J Infect Dis. 2025 Feb 20; 231(2):e328-e336.
Score: 0,208
-
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
Score: 0,162
-
The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine. 2018 02 08; 36(7):997-1007.
Score: 0,127
-
Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study. Influenza Other Respir Viruses. 2016 07; 10(4):324-32.
Score: 0,111
-
Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. PLoS One. 2014; 9(4):e94681.
Score: 0,098
-
Health and economic burden of influenza-associated illness in South Africa, 2013-2015. Influenza Other Respir Viruses. 2019 09; 13(5):484-495.
Score: 0,035